If You Invested in INTRALINKS HL (IL)
Looking for the current price? See the IL quote & overviewWhat $1,000 or $10,000 in IL Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Sep 28, 2015 |
|---|---|---|---|---|
| $1,000 | — | — | $1,321 +32% | $1,558 +56% |
| $10,000 | — | — | $13,208 +32% | $15,581 +56% |
Based on real historical closing prices, dividend- and split-adjusted, through 2017-01-19. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for IL$1,000 Investment Over Time
IL vs S&P 500Year-by-Year Returns
IL annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015 | $8.35 | $9.07 | +8.6% | +8.6% |
| 2016 | $8.77 | $13.52 | +54.2% | +61.9% |
| 2017 | $13.40 | $13.01 | -2.9% | +55.8% |
About INTRALINKS HL
NYSE
Instil Bio, Inc. (NASDAQ: IL) is identified in available disclosures as a company whose stock has been the subject of securities law investigations. Public information shows that investors’ rights law firm Holzer & Holzer, LLC announced an investigation into whether Instil Bio, Inc. complied with federal securities laws in connection with its clinical programs. The company’s shares trade under the ticker symbol IL on the NASDAQ exchange.
According to Holzer & Holzer, Instil Bio announced a pause in enrollment in its ongoing clinical trials of ITIL-168 and ITIL-306 after reporting a decrease in the rate of successful manufacturing of ITIL-168. This manufacturing issue led to an inability to dose some patients whose individual product of ITIL-168 was not successfully manufactured. Following that announcement, the company’s stock price declined, prompting the law firm’s investigation on behalf of shareholders who may have experienced losses.
The available information characterizes Instil Bio as a company engaged in clinical trials involving ITIL-168 and ITIL-306. These references indicate a focus on investigational therapies that require individualized manufacturing processes for patient dosing. The pause in enrollment described in the disclosure highlights the importance of manufacturing reliability for the company’s clinical and business activities.
Because the accessible data centers on legal and investor-related communications rather than a full corporate profile, many typical company details—such as founding history, headquarters location, and detailed business segments—are not specified in the provided sources. Investors and researchers looking at the IL stock symbol therefore encounter a narrative that is primarily framed around clinical trial manufacturing challenges and related securities law questions.
Any assessment of Instil Bio, Inc. (IL) based on this information should recognize that the key publicly cited events involve the pause in trial enrollment, the manufacturing issues for ITIL-168, and the subsequent investigation announced by Holzer & Holzer, LLC. Without additional official filings or descriptions, further details about the company’s broader operations, strategy, or financial profile are not available in the sources referenced here.
Frequently Asked Questions
INTRALINKS HL investment returns
How much would $1,000 invested in INTRALINKS HL be worth today?
If you invested $1,000 in INTRALINKS HL (IL) 10 years ago on 2016-09-26, your investment would be worth $1,321 as of 2017-01-19, representing a +32.1% total return, growing at a compounded rate of 142.0% per year (CAGR).
Has INTRALINKS HL outperformed the S&P 500?
Over the past 10 years, IL returned +32.1% compared to +308.6% for the S&P 500, underperforming the benchmark by 276.5 percentage points.
What is INTRALINKS HL's average annual return?
The compound annual growth rate (CAGR) of IL over the past 10 years is 142.0%, growing at a compounded rate each year. Individual years vary significantly — IL's best recent year was 2016 (+54.2%) and worst was 2017 (-2.9%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
